Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Finasteride reduces some inflammation in BPH but not all.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

T cells affect skin cell genes in inflammatory diseases, and therapy can normalize these changes.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Blocking IL-17 signaling can delay skin aging and improve skin and hair health.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Targeting regulatory T cells may help treat age-related diseases.

Sex and race affect immune responses and treatment outcomes in Hidradenitis suppurativa.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Hidradenitis suppurativa tunnels have different microenvironments, suggesting targeted treatments could be more effective.

Gingerol may help treat chronic graft-versus-host disease by improving immune cell balance.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.